T1	Participants 327 523	andomised patients aged 0-14 years inclusive with an initial white blood count of less than 100 x 10(9)/l to receive an early intensification block, a late intensification block, both, or neither.
T2	Participants 550 590	for children aged 1-14 years, randomised
T3	Participants 689 789	all patients were also randomised between late intensification alone and both early plus late blocks
